Related Experiment Videos
Non steroidal anti-inflammatory drugs and colorectal cancer: is there a way forward?
1University Department of Surgery, University of Newcastle upon Tyne, U.K.
Abstract:
Non steroidal anti-inflammatory drugs (NSAIDs) have diverse clinical applications through modulation of oxidative processes and cell signalling. Observations that these agents may inhibit human colorectal carcinogenesis have produced great excitement. However, comparative data relating to their chemopreventative effectiveness or to relevant mechanisms of action remains unclear. This review considers the clinical and epidemiological evidence for colorectal tumour prevention by NSAIDs against current concepts of drug mechanisms. We also propose areas of further research for potential therapeutic advancement.
Insights
Non-steroidal anti-inflammatory drugs (NSAIDs) show promise in preventing colorectal cancer. Further research is needed to clarify their effectiveness and mechanisms for therapeutic advancement.
Area of Science:
- Oncology
- Pharmacology
- Gastroenterology
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) modulate oxidative processes and cell signaling.
- NSAIDs have shown potential in inhibiting human colorectal carcinogenesis.
- Comparative data on NSAID chemopreventative effectiveness and mechanisms is limited.
Purpose of the Study:
- To review clinical and epidemiological evidence for NSAID-mediated colorectal tumor prevention.
- To examine current concepts of NSAID mechanisms of action in cancer prevention.
- To propose future research directions for therapeutic advancement.
Main Methods:
- Literature review of clinical studies.
- Epidemiological data analysis.
- Examination of pharmacological mechanisms.
Main Results:
- NSAIDs demonstrate potential in colorectal cancer chemoprevention.
- Evidence suggests modulation of oxidative stress and cell signaling pathways.
- Mechanisms underlying NSAID chemopreventative effects require further elucidation.
Conclusions:
- NSAIDs represent a promising strategy for colorectal cancer prevention.
- Understanding drug mechanisms is crucial for optimizing therapeutic use.
- Further research is warranted to advance NSAID-based chemoprevention.